Resources

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (September 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

Presentations from the 2019 MS Summit

View Presentations here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (June 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (April 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

MS Coalition Brochure (January 2012)

The Multiple Sclerosis Coalition (MSC) was founded in 2005 by three independent multiple sclerosis (MS) organizations in an effort to work together to benefit individuals with MS. Since that time, the MSC has grown to nine member organizations, all of whom provide critical MS programs and services.    Download here

Follow us on Twitter

TwitterFollow

MS Coalition
Retweet on TwitterMS Coalition Retweeted
MSHealthCentralMSHealthCentral@MSHealthCentral·
17 May

A writer and designer with multiple sclerosis details the practical, emotional, and financial survival strategies she wish she’d had when first diagnosed.

http://ow.ly/9sEE50EDUCm

Reply on Twitter 1394345736641425411Retweet on Twitter 13943457366414254112Like on Twitter 13943457366414254111Twitter 1394345736641425411
Retweet on TwitterMS Coalition Retweeted
iConquerMSiConquerMS@iConquerMS·
13 May

How well and how safely do the #COVID_19 vaccines work in people with #MS? Join the COVER-MS study and help answer that important question! Learn more and sign up here: http://bit.ly/cover-ms

Reply on Twitter 1392832885653049346Retweet on Twitter 13928328856530493462Like on Twitter 13928328856530493465Twitter 1392832885653049346
Load More...